Related Experiment Video
Updated: Dec 11, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Generation of Myocardial Ischemic Wounds and Healing with Stem Cells
1Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
Insights
Hematopoietic stem cell therapy shows promise for repairing cardiac tissue damaged by myocardial ischemia. Further research is needed to develop effective stem cell treatments for cardiovascular diseases.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Myocardial ischemia, a common cardiovascular disease manifestation, affects millions globally.
- Current treatments address cardiac damage post-ischemic injury but do not repair damaged tissue.
- Stem cell therapy offers a promising avenue for cardiac tissue regeneration.
Purpose of the Study:
- To detail methods for generating an animal model of myocardial ischemia.
- To describe hematopoietic stem cell expansion on nanofiber scaffolds.
- To outline the administration of cells for verifying therapeutic efficacy in ischemic animals.
Main Methods:
- Establishment of a preclinical animal model for myocardial ischemia.
- Cultivation of hematopoietic stem cells using a nanofiber scaffold.
- In vivo administration of expanded stem cells into the ischemic cardiac model.
Main Results:
- The protocol facilitates the generation of a relevant myocardial ischemia model.
- Successful expansion of viable hematopoietic stem cells on nanofiber scaffolds was achieved.
- Cell administration into the ischemic model allows for efficacy verification.
Conclusions:
- This protocol provides a framework for advancing stem cell-mediated cardiac repair research.
- Further investigation is crucial for translating stem cell therapies into clinical practice for cardiovascular diseases.
- The described methods support preclinical evaluation of stem cell efficacy in myocardial ischemia.
Abstract:
Myocardial ischemia is a common manifestation of cardiovascular diseases (CVD) that affects the health and lives of millions of people worldwide. While numerous treatment options exist that address cardiac damage after ischemic injury, none of these can repair damaged cardiac tissue. Stem cell-mediated therapy is an emerging approach for cardiac tissue regeneration that has shown promise in preclinical models and in clinical studies. However, much more research in this field must be carried out to bring effective stem cell therapies to clinical settings. This protocol discusses the methods for generation of an animal model of myocardial ischemia in a preclinical setting, expansion of viable hematopoietic stem cells on a nanofiber scaffold, and administration of cells into the ischemic animal to verify therapeutic efficacy.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Clinical Applications of Epidermal Stem Cells
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...

